These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8687977)

  • 1. Human calcitonin has the same inhibitory effect on osteoclastic bone resorption by human giant cell tumor cells as salmon calcitonin.
    Iida S; Kakudo S; Mori Y; Matsui M; Magota K; Kitajima Y; Nakamura N; Mano H; Hakeda Y; Azuma H; Kurokawa T; Kumegawa M
    Calcif Tissue Int; 1996 Aug; 59(2):100-4. PubMed ID: 8687977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcitonin receptor regulation and responsiveness to calcitonin in human osteoclast-like cells prepared in vitro using receptor activator of nuclear factor-kappaB ligand and macrophage colony-stimulating factor.
    Samura A; Wada S; Suda S; Iitaka M; Katayama S
    Endocrinology; 2000 Oct; 141(10):3774-82. PubMed ID: 11014233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacologic evaluation of the calcitonin analogue SB 205614 in models of osteoclastic bone resorption in vitro and in vivo: comparison with salmon calcitonin and elcatonin.
    McSheehy PM; Farina C; Airaghi R; Allievi E; Banfi S; Bertolini D; Ferni G; Frattola D; Oneta S; Pinza M
    Bone; 1995 Apr; 16(4):435-44. PubMed ID: 7605704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of continuous calcitonin treatment on osteoclast-like cell development and calcitonin receptor expression in mouse bone marrow cultures.
    Ikegame M; Rakopoulos M; Martin TJ; Moseley JM; Findlay DM
    J Bone Miner Res; 1996 Apr; 11(4):456-65. PubMed ID: 8992876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute effects of calcitonin on osteoclasts in man.
    Singer FR; Melvin KE; Mills BG
    Clin Endocrinol (Oxf); 1976; 5 Suppl():333S-340S. PubMed ID: 1053251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of continuous calcitonin treatment on osteoclasts derived from cocultures of mouse marrow stromal and spleen cells.
    Liu BY; Wang JT; Leu JS; Chiang CP; Hsieh CC; Kwan HW
    J Formos Med Assoc; 2000 Feb; 99(2):140-50. PubMed ID: 10770029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time course of "escape" from calcitonin-induced inhibition of motility and resorption of disaggregated osteoclasts.
    Kanehisa J
    Bone; 1989; 10(2):125-9. PubMed ID: 2765310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced potency of human calcitonin when fibrillation is avoided.
    Cudd A; Arvinte T; Das RE; Chinni C; MacIntyre I
    J Pharm Sci; 1995 Jun; 84(6):717-9. PubMed ID: 7562410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effect of salmon calcitonin on bone resorption: morphological study of the tibial growth plate in rats.
    Pazzaglia UE; Zatti G; Di Nucci A; Coci A
    Calcif Tissue Int; 1993 Feb; 52(2):125-9. PubMed ID: 8443688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone resorption by macrophage polykaryons of a pilar tumor of scalp.
    Athanasou NA; Quinn JM
    Cancer; 1992 Jul; 70(2):469-75. PubMed ID: 1617596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcitonin receptor down-regulation relates to calcitonin resistance in mature mouse osteoclasts.
    Wada S; Udagawa N; Nagata N; Martin TJ; Findlay DM
    Endocrinology; 1996 Mar; 137(3):1042-8. PubMed ID: 8603572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term culture of disaggregated rat osteoclasts: inhibition of bone resorption and reduction of osteoclast-like cell number by calcitonin and PTHrP[107-139].
    Fenton AJ; Martin TJ; Nicholson GC
    J Cell Physiol; 1993 Apr; 155(1):1-7. PubMed ID: 8468357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of the antiresorptive activity of salmon calcitonin microspheres using cultured osteoclastic cells.
    Dani BA; Raiche AT; Puleo DA; DeLuca PP
    AAPS PharmSciTech; 2002; 3(3):E21. PubMed ID: 12916936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the calcitonin receptor in bone marrow cell cultures and in bone: a specific marker of the differentiated osteoclast that is regulated by calcitonin.
    Lee SK; Goldring SR; Lorenzo JA
    Endocrinology; 1995 Oct; 136(10):4572-81. PubMed ID: 7664679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteoclast 121F antigen expression during osteoblast conditioned medium induction of osteoclast-like cells in vitro: relationship to calcitonin responsiveness, tartrate resistant acid phosphatase levels, and bone resorptive activity.
    Collin-Osdoby P; Oursler MJ; Rothe L; Webber D; Anderson F; Osdoby P
    J Bone Miner Res; 1995 Jan; 10(1):45-58. PubMed ID: 7747630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study of disaggregated chick and rat osteoclasts in vitro: effects of calcitonin and prostaglandins.
    Arnett TR; Dempster DW
    Endocrinology; 1987 Feb; 120(2):602-8. PubMed ID: 3467966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of calcium-regulating hormones and prostaglandins on bone resorption by osteoclasts disaggregated from neonatal rabbit bones.
    Chambers TJ; McSheehy PM; Thomson BM; Fuller K
    Endocrinology; 1985 Jan; 116(1):234-9. PubMed ID: 3880540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular and hormonal factors influencing monocyte differentiation to osteoclastic bone-resorbing cells.
    Quinn JM; McGee JO; Athanasou NA
    Endocrinology; 1994 Jun; 134(6):2416-23. PubMed ID: 8194468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcitonin gene-related peptide inhibits osteoclastic bone resorption: a comparative study.
    Zaidi M; Fuller K; Bevis PJ; GainesDas RE; Chambers TJ; MacIntyre I
    Calcif Tissue Int; 1987 Mar; 40(3):149-54. PubMed ID: 3105845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physiological levels of calcitonin regulate the mouse osteoclast calcitonin receptor by a protein kinase Alpha-mediated mechanism.
    Wada S; Udagawa N; Nagata N; Martin TJ; Findlay DM
    Endocrinology; 1996 Jan; 137(1):312-20. PubMed ID: 8536630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.